West Pharmaceutical
731 hedge funds and large institutions have $26B invested in West Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 251 increasing their positions, 269 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
731
Holders Change
+39
Holders Change %
+5.64%
% of All Funds
11.53%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.16%
New
93
Increased
251
Reduced
269
Closed
50
Calls
$52M
Puts
$26.5M
Net Calls
+$25.5M
Net Calls Change
-$10.5M
Top Buyers
| 1 |
Man Group
London,
United Kingdom
|
+$96.2M |
| 2 |
JPMorgan Chase & Co
New York
|
+$37.1M |
| 3 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$36.9M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$24.4M |
| 5 |
KBC Group
Brussels,
Belgium
|
+$23M |
Top Sellers
| 1 |
Neuberger Berman Group
New York
|
-$92.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$87.3M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$78.8M |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
-$73.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$61.2M |